NYSE:PFEPharmaceuticals
Is Pfizer (PFE) Offering Value After Recent Share Price Weakness?
If you are wondering whether Pfizer's current share price reflects its true worth, starting with the recent share performance and valuation checks can help frame that question clearly.
The stock closed at US$26.48, with a 3.0% decline over the last 7 days and a 2.1% decline over 30 days, while year to date it is up 5.2% and the 1 year return is 19.4%. This compares with declines of 18.8% over 3 years and 14.9% over 5 years.
Recent coverage around Pfizer has focused on its position as a major...

